Fed. Circ. Affirms PTAB Ax Of Omni MedSci IP In Apple Row
The Federal Circuit on Wednesday upheld two Patent Trial and Appeal Board decisions that invalidated claims in two Omni MedSci patents on devices for taking noninvasive physiological measurements, solidifying Apple's wins...To view the full article, register now.
Already a subscriber? Click here to view full article